Activating Compound | Comment | Organism | Structure |
---|---|---|---|
lithium/SB-415286 | two GSK-3 inhibitor, enhance caspase-8 activity in hepatoma cells, but not in healthy hepatocyte, and increase the sensitivity of the cells to tumor necrosis factor-related apoptosis-inducing ligand, i.e. TRAIL, or CH-11, a CD95 agonistic antibody, which leads to increased apoptosis, the agents have no effect alone, mechanism, overview, 1.5-2.1fold activation of CH-11-induced apoptosis at 20 mM LiCl and 0.025 mM SB-415286 | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N-carbobenzyloxy-VAD-fluoromethyl ketone | the pan-caspase inhibitor prevents the sensitizing effects of lithium and SB-415286 | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | activation of caspase-8 by glycogen synthase kinase-3 inhibitors can overcome the striking resistance to tumor necrosis factor-related apoptosis-inducing ligand, TRAIL, diplayed by hepatocellular carcinoma cells in contrast to normal heptocytes, overview | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HEP-3B cell | - |
Homo sapiens | - |
Hep-G2 cell | - |
Homo sapiens | - |
hepatocyte | - |
Homo sapiens | - |
hepatoma cell | - |
Homo sapiens | - |
HuH-6 cell | - |
Homo sapiens | - |
Mahlavu cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | activation of caspase-8 by glycogen synthase kinase-3 inhibitors can overcome the striking resistance to tumor necrosis factor-related apoptosis-inducing ligand, TRAIL, diplayed by hepatocellular carcinoma cells in contrast to normal heptocytes, overview | Homo sapiens | ? | - |
? |